Vitamin B3 Shows Promise in Glioblastoma Trial
Vitamin B3 and Glioblastoma
A recent clinical trial is investigating whether high doses of vitamin B3 (niacin) can improve outcomes for patients with glioblastoma, one of the most aggressive brain cancers.
How it Works
Researchers believe niacin can revive immune cells that tumors suppress, enabling the immune system to target cancer cells more effectively.
Early Results
Preliminary data indicate that patients receiving niacin show significantly better progression‑free survival than expected, suggesting a potential new adjunctive therapy for glioblastoma.
Next Steps
Further trials are needed to confirm efficacy, determine optimal dosing, and assess long‑term safety.